Epidermal Growth Factor Promotes Proliferation and Improves Restoration After Intestinal Ischemia-reperfusion Injury in Rats

Overview

Journal Inflammation

Specialties Allergy & Immunology
Pathology

Date 2013 Feb 12

PMID 23397076

Citations 11

Authors

YanXia Geng

Jieshou Li

Fan Wang

Qiurong Li

Xing Wang

Liqun Sun

Weiqin Li

Affiliations

Soon will be listed here.

Abstract

Epidermal growth factor (EGF) is an attractive and promising therapeutic application for intestinal disorders. The current study examined its influence on proliferation and restoration after ischemia-reperfusion (I/R) injury in rat small intestine. Six groups were performed: sham operation (Con); ischemia for 30 min with subsequent reperfusion for 30 min (I/R); I/R injured with 500 μg/kg EGF injected 5 min before ischemia (Pre-l); I/R injured with 50 μg/kg EGF injected 5 min before ischemia (Pre-s); I/R injured with 500 μg/kg EGF injected 5 min after reperfusion (Post-l); and I/R injured with 50 μg/kg EGF injected 5 min after reperfusion (Post-s). Intestinal histological damage, crypt cell proliferation degree, mucosal permeability, tight junction proteins expression, and levels of inflammation factors were studied for each group. Compared with the I/R group, administration of EGF in the Pre-l, Pre-s, and Post-l groups all presented a significant proliferation effect. The levels of FD4, IL-6, and TNF-α were dramatically decreased in all EGF-treated groups. Histological destruction was improved and TJs recovery was notably accelerated in all EGF-treated groups except the Post-s group. D-lactate concentration was only diminished in the Pre-l group. These results suggest that mucosally applied EGF can promote intestinal proliferation and improve restoration after I/R injury. EGF intraluminal administration is an effective treatment against intestinal I/R injury.

Citing Articles

Intestinal oxygen utilisation and cellular adaptation during intestinal ischaemia-reperfusion injury.

Archontakis-Barakakis P, Mavridis T, Chlorogiannis D, Barakakis G, Laou E, Sessler D Clin Transl Med. 2024; 15(1):e70136.

PMID: 39724463 PMC: 11670310. DOI: 10.1002/ctm2.70136.

Therapeutic implication of Sonic Hedgehog as a potential modulator in ischemic injury.

Mohan M, Mannan A, Singh T Pharmacol Rep. 2023; 75(4):838-860.

PMID: 37347388 DOI: 10.1007/s43440-023-00505-0.

Evaluation of small intestinal damage in a rat model of 6 Minutes cardiac arrest.

Schroeder D, Maul A, Mahabir E, Koxholt I, Yan X, Padosch S BMC Anesthesiol. 2018; 18(1):61.

PMID: 29866034 PMC: 5993127. DOI: 10.1186/s12871-018-0530-8.

Epidermal Growth Factor, through Alleviating Oxidative Stress, Protect IPEC-J2 Cells from Lipopolysaccharides-Induced Apoptosis.

Tang X, Liu B, Wang X, Yu Q, Fang R Int J Mol Sci. 2018; 19(3).

PMID: 29538305 PMC: 5877709. DOI: 10.3390/ijms19030848.

Salivary epidermal growth factor correlates with hospitalization length in rotavirus infection.

Gomez-Rial J, Curras-Tuala M, Talavero-Gonzalez C, Rodriguez-Tenreiro C, Vilanova-Trillo L, Gomez-Carballa A BMC Infect Dis. 2017; 17(1):370.

PMID: 28558652 PMC: 5450176. DOI: 10.1186/s12879-017-2463-0.

References

Sullivan P, Lewindon P, Cheng C, Lenehan P, Kuo B, Haskins J . Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis. J Pediatr Surg. 2007; 42(3):462-9. DOI: 10.1016/j.jpedsurg.2006.10.039. View

Palomino A, Hernandez-Bernal F, Haedo W, Franco S, Mas J, Fernandez J . A multicenter, randomized, double-blind clinical trial examining the effect of oral human recombinant epidermal growth factor on the healing of duodenal ulcers. Scand J Gastroenterol. 2000; 35(10):1016-22. DOI: 10.1080/003655200451126. View

Murray M, Gonze M, Nowak L, Cobb C . Serum D(-)-lactate levels as an aid to diagnosing acute intestinal ischemia. Am J Surg. 1994; 167(6):575-8. DOI: 10.1016/0002-9610(94)90101-5. View

Fanning A, Jameson B, Jesaitis L, Anderson J . The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem. 1998; 273(45):29745-53. DOI: 10.1074/jbc.273.45.29745. View

Feldman G, Mullin J, Ryan M . Occludin: structure, function and regulation. Adv Drug Deliv Rev. 2005; 57(6):883-917. DOI: 10.1016/j.addr.2005.01.009. View

Scheving L, Shiurba R, Nguyen T, Gray G . Epidermal growth factor receptor of the intestinal enterocyte. Localization to laterobasal but not brush border membrane. J Biol Chem. 1989; 264(3):1735-41. View

Sun X, Fu X, Zhang R, Lu Y, Deng Q, Jiang X . Relationship between plasma D(-)-lactate and intestinal damage after severe injuries in rats. World J Gastroenterol. 2002; 7(4):555-8. PMC: 4688672. DOI: 10.3748/wjg.v7.i4.555. View

Berlanga-Acosta J, Gavilondo-Cowley J, Lopez-Saura P, Gonzalez-Lopez T, Castro-Santana M, Lopez-Mola E . Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications. Int Wound J. 2009; 6(5):331-46. PMC: 7951530. DOI: 10.1111/j.1742-481X.2009.00622.x. View

Goodlad R, Wilson T, Lenton W, Gregory H, McCullagh K, Wright N . Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats. Gut. 1987; 28(5):573-82. PMC: 1432884. DOI: 10.1136/gut.28.5.573. View

10.

Dominguez J, Coopersmith C . Can we protect the gut in critical illness? The role of growth factors and other novel approaches. Crit Care Clin. 2010; 26(3):549-65, x. PMC: 2908596. DOI: 10.1016/j.ccc.2010.04.005. View

11.

Inoue K, Oyamada M, Mitsufuji S, Okanoue T, Takamatsu T . Different changes in the expression of multiple kinds of tight-junction proteins during ischemia-reperfusion injury of the rat ileum. Acta Histochem Cytochem. 2007; 39(2):35-45. PMC: 1828083. DOI: 10.1267/ahc.05048. View

12.

Clark J, Lane R, MacLennan N, Holubec H, Dvorakova K, Halpern M . Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2004; 288(4):G755-62. DOI: 10.1152/ajpgi.00172.2004. View

13.

Clark J, Doelle S, Halpern M, Saunders T, Holubec H, Dvorak K . Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol. 2006; 291(5):G938-49. DOI: 10.1152/ajpgi.00090.2006. View

14.

Dembinski A, Gregory H, Konturek S, Polanski M . Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol. 1982; 325:35-42. PMC: 1251377. DOI: 10.1113/jphysiol.1982.sp014133. View

15.

Villa X, Kuluz J, Schleien C, Thompson J . Epidermal growth factor reduces ischemia-reperfusion injury in rat small intestine. Crit Care Med. 2002; 30(7):1576-80. DOI: 10.1097/00003246-200207000-00030. View

16.

Carpenter G, Cohen S . Epidermal growth factor. Annu Rev Biochem. 1979; 48:193-216. DOI: 10.1146/annurev.bi.48.070179.001205. View

17.

Meng Z, Dyer K, Billiar T, Tweardy D . Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol. 2001; 280(2):C343-51. DOI: 10.1152/ajpcell.2001.280.2.C343. View

18.

Yang R, Han X, Uchiyama T, Watkins S, Yaguchi A, Delude R . IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol. 2003; 285(3):G621-9. DOI: 10.1152/ajpgi.00177.2003. View

19.

Ulshen M, Raasch R . Effects of intraluminal epidermal growth factor on mucosal proliferation in the small intestine of adult rats. Gastroenterology. 1986; 91(5):1134-40. DOI: 10.1016/s0016-5085(86)80008-7. View

20.

Miller C, Debas H . Epidermal growth factor stimulates the restitution of rat gastric mucosa in vitro. Exp Physiol. 1995; 80(6):1009-18. DOI: 10.1113/expphysiol.1995.sp003898. View